UPDATE: JPMorgan Upgrades Neurocrine Bio. (NBIX) to Overweight
Tweet Send to a Friend
(Updated - November 17, 2021 3:33 AM EST)
JPMorgan analyst Anupam Rama upgraded Neurocrine Bio. (NASDAQ: NBIX) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Anupam Rama upgraded Neurocrine Bio. (NASDAQ: NBIX) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
